Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 30 Jul 2019 for ARRAY BIOPHARMA INC.
Filing timeline
BuySaleKyle Lefkoff
Insider track record
Disclosed buys
0
Disclosed sells
17
Signal history
Kyle Lefkoff: trading record in brief
This profile gathers the share dealings of Kyle Lefkoff across 2 companies, led by Array Biopharma Inc and Viridian Therapeutics, Inc.\DE. Between 29 October 2016 and 30 July 2019, the trades on record add up to 36 filings.
Sales make up the whole of the open-market record (17 sales, €3.4M). Outside the open market, there are 11 option exercises. In 2019 alone, the filings show no purchases and 3 sales.
On 30 July 2019 came the latest disclosure, a transaction in Array Biopharma Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kyle Lefkoff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
5,000 sharesCommon StockSEC:0001209191-19-043780:2
22,635 shares@ US$48.0017.3% of flowCommon StockSEC:0001209191-19-043780:0
85 shares@ US$48.000.1% of flowCommon StockSEC:0001209191-19-043780:1
20,000 shares@ US$48.0015.3% of flowCommon StockSEC:0001209191-19-043780:3
15,000 shares@ US$48.0011.5% of flowCommon StockSEC:0001209191-19-043780:4
30,000 shares@ US$48.0023.0% of flowCommon StockSEC:0001209191-19-043780:5
25,000 shares@ US$10.473.5% of flowCommon StockSEC:0001562180-19-000863:0
25,000 shares@ US$20.516.9% of flowCommon StockSEC:0001562180-19-000863:1
5,000 shares@ US$20.821.4% of flowCommon StockSEC:0001562180-19-000863:2
5,000 shares@ US$20.851.4% of flowCommon StockSEC:0001562180-19-000863:3
5,000 sharesCommon StockSEC:0001562180-18-004315:0
2,085 shares0Common StockSEC:0001562180-18-003681:0
25,000 shares@ US$5.131.7% of flowCommon StockSEC:0001209191-18-041857:0
25,000 shares@ US$5.951.9% of flowCommon StockSEC:0001209191-18-041857:1
50,000 shares@ US$17.4511.4% of flowCommon StockSEC:0001209191-18-041857:2
25,000 shares@ US$5.601.4% of flowCommon StockSEC:0001562180-18-000729:0
25,000 shares@ US$3.871.0% of flowCommon StockSEC:0001562180-18-000729:1
50,000 shares@ US$17.018.7% of flowCommon StockSEC:0001562180-18-000729:2
5,000 shares@ US$10.470.6% of flowCommon StockSEC:0001562180-17-003345:0
45,000 shares@ US$10.585.1% of flowCommon StockSEC:0001562180-17-003064:0
38,865 shares@ US$12.315.1% of flowCommon StockSEC:0001562180-17-003064:1
25,000 shares@ US$3.691.1% of flowCommon StockSEC:0001562180-17-001461:1
20,000 shares@ US$4.361.0% of flowCommon StockSEC:0001562180-17-001461:2
45,000 shares@ US$8.924.7% of flowCommon StockSEC:0001562180-17-001461:3
2,000 shares0Common StockSEC:0001562180-17-001461:0
25 of 36 declarations
